Sinopharm Group is a wholly-owned subsidiary of Shanghai Hyundai Pharmaceutical Co., Ltd. The company is located in the Pharmaceutical Industrial Park of Datong Economic and Technological Development Zone in Shanxi Province, and its holding company Sinopharm Group Datong Weiqida Zhongkang Pharmaceutical Co., Ltd. It covers an area of 1,314 acres and has 4,310 employees.

This project uses our company DBL-AP7 series reactive power compensation device. This major project uses our company's products to fully demonstrate the customer's recognition of Dibor's electrical quality.

The DBL-AP7 series reactive power compensation device consists of a cylindrical self-healing explosion-proof capacitor + filter reactor.

DBL cylindrical self-healing low-voltage shunt capacitors are used for power factor correction of 50Hz or 60Hz voltage power system equipment. They are suitable for local compensation and centralized compensation, which can reduce reactive power loss and improve power quality. It uses dry, self-healing and explosion-proof technology to ensure a long working life and low loss of the capacitor.

DBL high-performance reactors are divided into three-phase and single-phase, all of which are iron core dry type. The iron core adopts high-quality wear-resistant cold-rolled oriented silicon steel sheet, and the core column is divided into uniform small segments by a plurality of air gaps, and the air gap is isolated by Nomex insulating paper to ensure that the reactance air gap does not change during operation. The coil of the reactor is wound by a class H insulating enamel-coated copper wire. The arrangement is tight and uniform, and the outer surface does not contain an insulating layer. It has excellent aesthetics and good heat dissipation performance.